These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 567923)

  • 1. [Macroglobulin activated factor X inhibitor in human plasma (author's transl)].
    Imaoka S
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):579-83. PubMed ID: 567923
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of activated factor X-induced platelet aggregation: the role of heparin and the plasma inhibitor to activated factor X.
    Yin ET; Giudice LC; Wessler S
    J Lab Clin Med; 1973 Sep; 82(3):390-8. PubMed ID: 4728289
    [No Abstract]   [Full Text] [Related]  

  • 3. [Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].
    Choay J; Lormeau JC; Petitou M
    Ann Pharm Fr; 1981 May; 39(1):37-44. PubMed ID: 7247232
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low molecular weight oligosaccharides active in plasma against factor Xa. II. New structural elements and antithrombotic activity (author's transl)].
    Choay J; Lormeau JC; Petitou M; Fareed J; Sinaÿ P
    Ann Pharm Fr; 1981 Jul; 39(3):267-72. PubMed ID: 7294654
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
    Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a naturally occurring plasma inhibitor of activated factor X: its isolation and partial purification.
    Yin ET; Wessler S
    Thromb Diath Haemorrh; 1969 Apr; 21(2):398-401. PubMed ID: 5769061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of serums and plasmas of various species on a protease of Staphylococcus aureus. Human alpha2-macroglobulin as an inhibitor (author's transl)].
    Papke G; Hasche KD; Brückler J; Blobel H
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):1-6. PubMed ID: 83750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circulatory collagenase inhibitor.
    Hawley PR; Faulk WP; Clark CG
    Br J Surg; 1970 Nov; 57(11):862. PubMed ID: 4320548
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies on alpha 2-macroglobulin. Serum antifibrinolytic activity and alpha 2-macroglobulin].
    Ando H
    Nihon Naika Gakkai Zasshi; 1970 Apr; 59(4):329-39. PubMed ID: 5462888
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on blood hypercoagulability and serum accerelating substance (author's transl)].
    Yatabe M; Ikematsu S; Mikami T; Hotta Y; Kato M
    Rinsho Byori; 1973 Nov; 21(11):914-9. PubMed ID: 4130637
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measurement of alpha 2-macroglobulin in human sera by quantitative inhibition of an acid staphylococcal protease (author's transl)].
    Neubüser U; Brückler J; Blobel H
    Zentralbl Bakteriol A; 1980; 247(2):164-9. PubMed ID: 6158814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acquired factor X inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids.
    Hsia CC; Keeney M; Bosco AA; Xenocostas A
    Am J Hematol; 2008 Apr; 83(4):318-20. PubMed ID: 17975806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological assay of antithrombin (anthrombin III and alpha2-macroglobulin) (author's transl)].
    Meguro T; Yamada K; Shirahata A
    Rinsho Byori; 1975 Aug; 23(8):635-8. PubMed ID: 811830
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the inhibition of the proteinases from Pseudomonas aeruginosa by alpha2-macroglobulin (author's transl)].
    Hochstrasser K; Theopold HM; Brandl O
    Hoppe Seylers Z Physiol Chem; 1973 Aug; 354(8):1013-6. PubMed ID: 4215723
    [No Abstract]   [Full Text] [Related]  

  • 17. Role for a 2 -macroglobulin in haemostatic balance.
    Rinderknecht H; Geokas MC
    Nat New Biol; 1972 Sep; 239(91):116-7. PubMed ID: 4507518
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel inhibitor of factor X activation from the salivary glands of the bed bug Cimex lectularius.
    Valenzuela JG; Guimaraes JA; Ribeiro JM
    Exp Parasitol; 1996 Jul; 83(2):184-90. PubMed ID: 8682187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The relationship between antithrombin III, progressive antithrombin activity and anti Xa activity in plasma.
    Whigham K; Howie PW; Forbes CD; Prentice CR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):365. PubMed ID: 52904
    [No Abstract]   [Full Text] [Related]  

  • 20. [alpha2-macroglobulin (author's transl)].
    Igarashi M; Takatsuka J; Shiba T; Takeuchi S
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):589-96. PubMed ID: 80906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.